ClinicalTrials.gov record
Recruiting Phase 2 Interventional

A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine

ClinicalTrials.gov ID: NCT06602479

Public ClinicalTrials.gov record NCT06602479. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 11:50 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomised, Multicentre, Parallel-Group Treatment, Double-Blind Study to Investigate the Safety and Efficacy of Subcutaneous MEDI0618 in the Reduction of Migraine Headache Days Compared to Placebo in Adult Participants With Episodic Migraine

Study identification

NCT ID
NCT06602479
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
AbbVie
Industry
Enrollment
488 participants

Conditions and interventions

Conditions

Interventions

  • MEDI0618 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 6, 2024
Primary completion
Dec 17, 2026
Completion
May 6, 2027
Last update posted
Jan 21, 2026

2024 – 2027

United States locations

U.S. sites
16
U.S. states
10
U.S. cities
16
Facility City State ZIP Site status
Flourish - Birmingham Birmingham Alabama 35205 Recruiting
Tennessee Valley Neurological Associates PC Huntsville Alabama 35801 Withdrawn
The Neurology Center of Southern California - Carlsbad Office La Jolla California 92037 Recruiting
Clinical Research Institute, LCC Los Angeles California 90048 Recruiting
Homestead Associates in Research, Inc. Homestead Florida 33033 Not yet recruiting
Florida Neurology - Lake Mary Lake Mary Florida 32746 Not yet recruiting
Flourish Research - Miami, LLC dba Flourish Research Miami Florida 33135 Recruiting
BayCare Medical Group Neurology at St. Anthony's Hospital St. Petersburg Florida 33705 Not yet recruiting
Santos Research Center, Corp - Tampa Tampa Florida 33615 Recruiting
Norton Neuroscience Institute - Headache Clinic Louisville Kentucky 40207 Withdrawn
Modern Migraine, MD New York New York 10001 Withdrawn
Velocity Clinical Research, Providence (East Greenwich) East Greenwich Rhode Island 02818 Not yet recruiting
Palmetto Primary Care Physicians Division of Gastroenterology - Summerville Summerville South Carolina 29486 Recruiting
FutureSearch Trials Austin Texas 78731 Recruiting
Vaught Neurological Services, PLLC Crab Orchard West Virginia 25827 Not yet recruiting
The Mind+ Neurology Clinic Mequon Wisconsin 53092 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 38 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06602479, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 21, 2026 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06602479 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →